Literature DB >> 27512419

Pregnancy outcomes in patients with severe pulmonary hypertension and Eisenmenger syndrome treated with sildenafil monotherapy.

Reinalyn S Cartago1, Pichy Ann Alan2, Jubert Benedicto3.   

Abstract

Pregnancy outcomes in patients with pulmonary arterial hypertension have not been documented in our local setting. In our institution, access to therapies like nitric oxide, inhaled prostacyclin and iloprost is limited. We describe two such women given sildenafil monotherapy between April and May 2011. Both had an atrial septal defect complicated by Eisenmenger syndrome. Both survived - one after elective Caesarean section for malpresentation (breech) under general anaesthesia, the other after an assisted vaginal delivery. In addition to oral sildenafil, both received oxygen supplementation. To date, there have been three reported cases of pulmonary arterial hypertension in pregnancy treated with sildenafil in combination with another drug. Our two cases demonstrate that treatment for pulmonary arterial hypertension using sildenafil as monotherapy may allow stabilization of the maternal condition and improve clinical outcomes for both mother and baby. However, pregnancy is still discouraged in women with pulmonary arterial hypertension.

Entities:  

Keywords:  High-risk pregnancy; complications

Year:  2014        PMID: 27512419      PMCID: PMC4934936          DOI: 10.1177/1753495X13514403

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  5 in total

Review 1.  Heart disease and pregnancy.

Authors:  S C Siu; J M Colman
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

2.  A 31-year-old pregnant woman with progressive exertional dyspnea and differential cyanosis.

Authors:  Wen-Ru Chou; Ping-Hung Kuo; Jin-Chung Shih; Pan-Chyr Yang
Journal:  Chest       Date:  2004-08       Impact factor: 9.410

3.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

4.  ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association.

Authors:  Vallerie V McLaughlin; Stephen L Archer; David B Badesch; Robyn J Barst; Harrison W Farber; Jonathan R Lindner; Michael A Mathier; Michael D McGoon; Myung H Park; Robert S Rosenson; Lewis J Rubin; Victor F Tapson; John Varga
Journal:  J Am Coll Cardiol       Date:  2009-04-28       Impact factor: 24.094

5.  Management of Eisenmenger syndrome in pregnancy with sildenafil and L-arginine.

Authors:  Héctor J Lacassie; Alfredo M Germain; Gloria Valdés; M Soledad Fernández; Francisco Allamand; Héctor López
Journal:  Obstet Gynecol       Date:  2004-05       Impact factor: 7.661

  5 in total
  1 in total

Review 1.  Sildenafil during the 2nd and 3rd Trimester of Pregnancy: Trials and Tribulations.

Authors:  Felix Rafael De Bie; David Basurto; Sailesh Kumar; Jan Deprest; Francesca Maria Russo
Journal:  Int J Environ Res Public Health       Date:  2022-09-06       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.